Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

  • Paola Anna Jablonska,
  • Ricardo Diez-Valle,
  • Jaime Gállego Pérez-Larraya,
  • Marta Moreno-Jiménez,
  • Miguel Ángel Idoate,
  • Leire Arbea,
  • Sonia Tejada,
  • Maria Reyes Garcia de Eulate,
  • Luis Ramos,
  • Javier Arbizu,
  • Pablo Domínguez,
  • José Javier Aristu

Correction: Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience

  • Paola Anna Jablonska, 
  • Ricardo Diez-Valle, 
  • Jaime Gállego Pérez-Larraya, 
  • Marta Moreno-Jiménez, 
  • Miguel Ángel Idoate, 
  • Leire Arbea, 
  • Sonia Tejada, 
  • Maria Reyes Garcia de Eulate, 
  • Luis Ramos, 
  • Javier Arbizu
PLOS
x
  • Article
  • Metrics
  • Comments
  • Media Coverage

There is an error in the XML of the article. As a result, the third author’s name is listed in the citation incorrectly. The correct citation is: Jablonska PA, Diez-Valle R, Gállego Pérez-Larraya J, Moreno-Jiménez M, Idoate MÁ, Arbea L, et al. (2019) Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS ONE 14(6): e0217881. https://doi.org/10.1371/journal.pone.0217881

Reference

  1. 1. Jablonska PA, Diez-Valle R, Pérez-Larraya JG, Moreno-Jiménez M, Idoate MÁ, Arbea L, et al. (2019) Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience. PLoS ONE 14(6): e0217881. https://doi.org/10.1371/journal.pone.0217881 pmid:31170245